-
Forward Look
The Dense Breast DebateSome states are mandating that doctors tell patients about breast density, which can affect cancer risk.
by Mitzi Baker
-
The Family Cancer Tree
Accurate reporting of family histories could be key to risk reduction.
by Mitzi Baker
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
The HPV Cancer Connection: Take 2
New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.
by Alanna Kennedy-Gorman
-
Healthy Habits
Just Another Meatless MondayMake room for tasty vegetarian dishes in your weekly menu.
by Alanna Kennedy-Gorman
-
Forward Look
Cancer Screening: A Dose of RealityQ&A with H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.
by Sue Rochman
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
-
Forward Look
The Avastin Roller CoasterUps and downs keep coming for Avastin as studies report on its effects for different cancers.
by Sue Rochman
-
Clinical Trials Game-Changer?
A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?
by Sue Rochman
Cancer Talk
Most Cancer Survivors Don’t Meet Healthy Diet Goals
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon